Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Annotation

Georgieva L, Moskvina V, Peirce T, Norton N, Bray NJ, Jones L, Holmans P, Macgregor S, Zammit S, Wilkinson J, Williams H, Nikolov I, Williams N, Ivanov D, Davis KL, Haroutunian V, Buxbaum JD, Craddock N, Kirov G, Owen MJ, O'Donovan MC. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc Natl Acad Sci U S A . 2006 Aug 15 ; 103(33):12469-74. PubMed Abstract

Comments on Paper and Primary News
Primary News: OLIG2 Gene Supports Notion of Myelin Abnormalities in Schizophrenia

Comment by:  William Honer
Submitted 4 August 2006 Posted 4 August 2006

This paper demonstrates several important shifts in research strategies for schizophrenia. Many previous studies of candidate genes in the illness have chosen their targets based on concepts of the mechanism of action of antipsychotic drugs, or by virtue of the proximity of a gene to a genetic linkage site defined with anonymous markers. The choice of candidate gene here is based on a wide range of neurobiological evidence, including studies of gene expression and protein levels. As well, the authors do not limit their study to one gene; instead, they expand their investigation to include plausibly interacting gene targets. Analysis of complex disorders will likely need more than simple models, and the approach here is worth noting.

The gap still remains between the DNA-mRNA approaches and protein analysis. Gene expression is one factor determining mRNA levels. However, especially in human brain tissue samples, many other antemortem and postmortem factors contribute to the measured level of mRNA. The meaning of gene expression measures obtained for...  Read more


View all comments by William Honer

Primary News: OLIG2 Gene Supports Notion of Myelin Abnormalities in Schizophrenia

Comment by:  Patricia Estani
Submitted 22 August 2006 Posted 23 August 2006
  I recommend this paper
Submit a Comment on this Paper
Make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend this paper

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


 
 
SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Share/Bookmark
 
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright